| Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron Z Cui, P Liu, N Wang, L Wang, K Fan, Q Zhu, K Wang, R Chen, R Feng, ... Cell 185 (5), 860-871. e13, 2022 | 383 | 2022 |
| Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants K Wang, Z Jia, L Bao, L Wang, L Cao, H Chi, Y Hu, Q Li, Y Zhou, Y Jiang, ... Nature 603 (7903), 919-925, 2022 | 167 | 2022 |
| Characterization of the enhanced infectivity and antibody evasion of Omicron BA. 2.75 Y Cao, W Song, L Wang, P Liu, C Yue, F Jian, Y Yu, A Yisimayi, P Wang, ... Cell host & microbe 30 (11), 1527-1539. e5, 2022 | 154 | 2022 |
| A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2 Z Jia, K Wang, M Xie, J Wu, Y Hu, Y Zhou, A Yisimayi, W Fu, L Wang, ... Protein & Cell, pwae033, 2024 | 53 | 2024 |
| Structural and molecular basis for foot-and-mouth disease virus neutralization by two potent protective antibodies H Dong, P Liu, M Bai, K Wang, R Feng, D Zhu, Y Sun, S Mu, H Li, ... Protein & Cell 13 (6), 446-453, 2022 | 29 | 2022 |
| Replication is the key barrier during the dual-host adaptation of mosquito-borne flaviviruses Y Zhang, D Liang, F Yuan, Y Yan, Z Wang, P Liu, Q Yu, X Zhang, X Wang, ... Proceedings of the National Academy of Sciences 119 (12), e2110491119, 2022 | 20 | 2022 |
| Host susceptibility and structural and immunological insight of S proteins of two SARS-CoV-2 closely related bat coronaviruses X Ou, G Xu, P Li, Y Liu, F Zan, P Liu, J Hu, X Lu, S Dong, Y Zhou, Z Mu, ... Cell discovery 9 (1), 78, 2023 | 19 | 2023 |
| Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity P Liu, C Yue, B Meng, T Xiao, S Yang, S Liu, F Jian, Q Zhu, Y Yu, Y Ren, ... National Science Review, nwae206, 2024 | 11 | 2024 |
| Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method Y Dou, K Xu, YQ Deng, Z Jia, J Lan, X Xu, G Zhang, T Cao, P Liu, X Wang, ... Antibody Therapeutics 6 (2), 76-86, 2023 | 4 | 2023 |
| Deletion of V483 in the spike confers evolutionary advantage on SARS-CoV-2 for human adaptation and host-range expansion after a prolonged pandemic C Yue, S Liu, B Meng, K Fan, S Yang, P Liu, Q Zhu, X Mao, Y Yu, F Shao, ... Cell Research 34 (10), 739-742, 2024 | 2 | 2024 |
| Foot-and-mouth disease virus antigenic landscape and reduced immunogenicity elucidated in atomic detail H Li, P Liu, H Dong, A Dekker, MM Harmsen, H Guo, X Wang, S Sun Nature Communications 15 (1), 8774, 2024 | | 2024 |
| Enhancing RBD exposure and S1 shedding by an extremely conserved SARS-CoV-2 NTD epitope Q Zhu, P Liu, S Liu, C Yue, X Wang Signal Transduction and Targeted Therapy 9 (1), 217, 2024 | | 2024 |